Nature Communications · 2021 · 215 citations · 45 references
MedicineOncologyPharmacologyCatalysisDrug DeliveryMolecular OncologyCancer NanomedicineNanocarriers For TherapeuticsNanomaterials For Drug DeliveryNanomedicinePhotocatalysisCancer NanotherapyIrradiation DamageIrradiation EffectsNanocarriersPhotocatalytic MaterialsPhotocatalytic NanomaterialsRedox Balance
Abstract Drug therapy unavoidably brings toxic side effects and drug content-limited therapeutic efficacy although many nanocarriers have been developed to improve them to a certain extent. In this work, a concept of drug-free therapeutics is proposed and defined as a therapeutic methodology without the use of traditional toxic drugs, without the consumption of therapeutic agents during treatment but with the inexhaustible therapeutic capability to maximize the benefit of treatment, and a Z-scheme SnS 1.68 -WO 2.41 nanocatalyst is developed to achieve near infrared (NIR)-photocatalytic generation of oxidative holes and hydrogen molecules for realizing combined hole/hydrogen therapy by the drug-free therapeutic strategy. Without the need of any drug and other therapeutic agent assistance, the nanocatalyst oxidizes/consumes intratumoral over-expressed glutathione (GSH) by holes and simultaneously generates hydrogen molecules in a lasting and controllable way under NIR irradiation. Mechanistically, generated hydrogen molecules and GSH consumption inhibit cancer cell energy and destroy intratumoral redox balance, respectively, to synergistically damage DNA and induce tumor cell apoptosis. High efficacy and biosafety of combined hole/hydrogen therapy of tumors are achieved by the nanocatalyst. The proposed catalysis-based drug-free therapeutic strategy breaks a pathway to realize high efficacy and low toxicity of cancer treatment.
45
A DNA nanorobot functions as a cancer therapeutic in response to a molecular trigger in vivo
Suping Li, Qiao Jiang, Shaoli Liu et al. · Nature Biotechnology · 2018 · 1.5K citations
Tumor-selective catalytic nanomedicine by nanocatalyst delivery
Minfeng Huo, Liying Wang, Yu Chen et al. · Nature Communications · 2017 · 1.3K citations · Full text